Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
CRIS | Curis, Inc. | Common Stock, Par Value $0.01 per share | 8% | $1.81M | 681K | Maverick Capital, Ltd. | Dec 31, 2024 | ||
WVE | Wave Life Sciences Ltd. | $0 Par Value Ordinary Shares | 5.4% | $84.8M | 8.26M | Maverick Capital, Ltd. | Dec 31, 2024 | ||
RCKT | Rocket Pharmaceuticals, Inc. | Common Stock, $0.01 par value | 5.2% | $48.8M | 5.55M | Maverick Capital, Ltd. | Apr 7, 2025 | ||
VRNA | Verona Pharma Plc | Ordinary Shares, nominal value 0.05 GBP per share | 3.8% | $1.69B | 25M | Maverick Capital, Ltd. | Dec 31, 2024 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|